Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral neuropathy associated with high-dose Ara-C therapy.

A Borgeat, B De Muralt, M Stalder

    Cancer
    |August 15, 1986
    PubMed
    Summary

    High-dose cytosine arabinoside (Ara-C) therapy can cause severe peripheral polyneuropathy. Patients receiving this treatment require thorough neurologic evaluations to detect potential neurotoxicity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties.

    Biochimica et biophysica acta. General subjects·2020
    Same author

    Lidocaine inhibits cytoskeletal remodelling and human breast cancer cell migration.

    British journal of anaesthesia·2018
    Same author

    Prevention of arterial hypotension after spinal anaesthesia using vena cava ultrasound to guide fluid management.

    British journal of anaesthesia·2018
    Same author

    Parecoxib, propacetamol, and their combination for analgesia after total hip arthroplasty: a randomized non-inferiority trial.

    Acta anaesthesiologica Scandinavica·2016
    Same author

    Archives of gynecology and obstetrics·2016
    Same author

    Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.

    British journal of anaesthesia·2015

    Area of Science:

    • Neuroscience
    • Oncology
    • Neurology

    Background:

    • High-dose cytosine arabinoside (Ara-C) is a chemotherapy agent used in treating various cancers.
    • Central nervous system toxicity is a known side effect of high-dose Ara-C therapy.

    Observation:

    • This report details a case of severe, isolated peripheral polyneuropathy in a patient undergoing high-dose Ara-C treatment.
    • The patient exhibited significant peripheral nerve dysfunction attributed to the chemotherapy.

    Findings:

    • Electrophysiologic studies indicated axonal degeneration.
    • Histologic examination revealed scattered destruction of myelin sheaths in peripheral nerves.
    • These findings confirm peripheral neuropathy as a potential adverse effect of high-dose Ara-C.

    Implications:

    • This case highlights the importance of comprehensive neurologic assessments for patients on high-dose Ara-C.
    • Early detection and management of peripheral neuropathy can improve patient outcomes.
    • Further research into the mechanisms of Ara-C-induced neurotoxicity is warranted.

    Related Experiment Videos